BioMed Research International

BioMed Research International / 2016 / Article
Special Issue

Advances in Translational Cancer Imaging: Opportunities and Challenges

View this Special Issue

Research Article | Open Access

Volume 2016 |Article ID 8279560 | 12 pages | https://doi.org/10.1155/2016/8279560

Analysis of Residual DSBs in Ataxia-Telangiectasia Lymphoblast Cells Initiating Apoptosis

Academic Editor: Yi-Xiang Wang
Received02 Sep 2015
Accepted01 Dec 2015
Published06 Jan 2016

Abstract

In order to examine the relationship between accumulation of residual DNA double-strand breaks (DSBs) and cell death, we have used a control and an ATM (Ataxia-Telangiectasia Mutated) defective cell line, as Ataxia-Telangiectasia (AT) cells tend to accumulate residual DSBs at long times after damage infliction. After irradiation, AT cells showed checkpoint impairment and a fraction of cells displayed an abnormal centrosome number and tetraploid DNA content, and this fraction increased along with apoptosis rates. At all times analyzed, AT cells displayed a significantly higher rate of radiation-induced apoptosis than normal cells. Besides apoptosis, 70–85% of the AT viable cells (TUNEL-negative) carried ≥10 γH2AX foci/cell, while only 12–27% of normal cells did. The fraction of AT and normal cells undergoing early and late apoptosis were isolated by flow cytometry and residual DSBs were concretely scored in these populations. Half of the γH2AX-positive AT cells undergoing early apoptosis carried ≥10 γH2AX foci/cell and this fraction increased to 75% in late apoptosis. The results suggest that retention of DNA damage-induced γH2AX foci is an indicative of lethal DNA damage, as cells undergoing apoptosis are those accumulating more DSBs. Scoring of residual γH2AX foci might function as a predictive tool to assess radiation-induced apoptosis.

1. Introduction

Following DNA double-strand breaks (DSBs) generation by ionizing radiation (IR), the cell undergoes an Ataxia-Telangiectasia Mutated (ATM) dependent p53 activation of the DNA damage response (DDR) cascade to activate the cell checkpoints in order to gain time for DNA repair [13]. If the DNA damage cannot be repaired during checkpoint arrest, cells are driven to undergo an irreversible fate by apoptosis or senescence [4, 5]. Sensing of the DNA damage involves the extensive phosphorylation of histone H2AX molecules at both sides of the DNA break [6]. Phosphorylated H2AX forms foci immediately after DNA damage induction by IR. These γH2AX IRIF (Ionizing Radiation-Induced Foci) are detectable with immunostaining or cytometry techniques as soon as 3 minutes afterwards, and the maximum number of foci is detected 30–60 minutes after irradiation [7]. The number of γH2AX foci has been found to closely correlate with the number of radiation-induced DSBs [8, 9]. Very soon after irradiation, γH2AX foci are numerous and small and they disappear along with resolution of DNA damage [8]. Nonetheless, several results have shown that radiosensitive cell lines retain γH2AX foci longer than radioresistant cell lines after exposure to radiation [1012]. The fraction of tumor cells that retain γH2AX foci 24 hours after irradiation has been correlated with the fraction of cells that fail to divide and form colonies [13, 14], suggesting that the H2AX assay can be used as an indicator of cell death. However, there are also negative studies that found no correlation between γH2AX and clonogenic cell survival [15, 16], demonstrating that it is yet unclear whether residual DSBs are ultimately related with apoptosis triggering.

Recently, apoptosis and mitotic catastrophe (MC) have been functionally linked [17, 18]. MC has been defined as an oncosuppressive mechanism resulting from a combination of deficient cell cycle checkpoints, persistence of DNA damage and mitotic failure, which can ultimately lead to cell death during mitosis or alternatively by apoptosis or senescence. This mechanism mainly operates in a cell-cycle-specific kinases-dependent and p53-dependent way to avoid accumulation of genomic instability and is prevalent in cancer cells that exhibit genomic instability and are devoid of proper checkpoint control [17, 19, 20].

The goal of this study was to examine the relationship between DNA damage accumulation and apoptosis. In radiosensitive ATM deficient cells, the defects in triggering the whole DDR following IR lead to checkpoint failure and to the accumulation of unresolved DSBs [1, 3], thus being an ideal model to study this relationship. Our results show that AT and normal lymphoblastoid cell lines undergoing apoptosis accumulate a higher number of γH2AX foci than those belonging to the viable fraction. Specifically, AT lymphoblasts accumulate a higher fraction of residual DSBs and undergo significantly higher levels of IR-induced apoptosis at all postirradiation (pIR) times analyzed. Also AT lymphoblasts display a strong G2/M arrest and tetraploidization, suggesting that MC contributes to apoptosis in ATM deficient cells.

2. Results and Discussion

2.1. AT Lymphoblasts Efficiently Trigger a p53-Dependent Apoptotic Response and Undergo High Levels of Radiation-Induced Apoptosis

In order to determine a relationship between persistent radiation-induced DSBs and apoptosis, we had to first determine the ability to undergo apoptosis in AT and normal lymphoblastoid cell lines (LCLs). To this end, Annexin-V (An) and propidium iodide (PI) incorporation in cells was measured by flow cytometry, and cells were analyzed at 0, 24, 48, and 72 hours after 5 Gy irradiation. Loss of plasma membrane asymmetry by exposing phosphatidylserine in the outer leaflet is an early event in the apoptotic process, previous to loss of membrane integrity and to DNA fragmentation. Thereby, cells positive for Annexin-V and negative for PI staining (An+/PI−) are considered to be undergoing early stages of apoptosis (EA) [2123]. Later in this process, cells lose membrane integrity, allowing PI staining. Therefore, cells that are An+/IP+ are considered to be in late apoptosis (LA), although necrotic cells can also be found in this fraction [21, 24].

As shown in Figure 1(a), the fraction of An+/PI− cells is higher in AT LCL at all times analyzed, even before irradiation. AT cells undergoing early apoptosis reach 8.0% and 12.5% at 24 hours and 48 hours pIR, respectively, while the fraction of normal cells An+/PI− during these time points is always lower than 5%. The overall fraction of Annexin-positive cells (sum of An+/PI− and An+/PI+ cells) reaches its maximum at 48 hours after irradiation, being 12.3% in normal LCL and 31.8% in AT LCL. At later time points, An+/PI− and An+/PI+ cells start to slowly decline, although they are still significantly higher in AT cells and far from the basal levels in both cell lines. These results demonstrate that this AT LCL not only efficiently triggers apoptosis, but also undergoes higher rates of radiation-induced apoptosis than its normal counterpart.

Because several works have reported contradictory results regarding apoptosis induction in AT cells [2531], we aimed to confirm the previous results obtained with Annexin-V/PI by analyzing radiation-induced apoptosis using TUNEL methodology. One characteristic feature of the later stages of apoptosis is the internucleosomal fragmentation of DNA into ~180 bp repeats often referred to as DNA laddering [32]. TUNEL allows the detection of these DNA fragments by labeling their 3′-OH end with a fluorescent molecule. AT and normal lymphoblasts were irradiated at the same dose of γ-rays (5 Gy), and apoptosis levels were analyzed at the same time points previously described. TUNEL was performed on slides and quantitation of TUNEL-positive cells was performed with an epifluorescence microscope. The majority of TUNEL-positive cells also displayed characteristic morphological features of apoptosis, such as nuclei shrinkage, DNA compaction, and nuclear fragmentation. All these features combined with TUNEL staining allowed certain detection of apoptotic cells (Figure 1(b)).

As shown in Figure 1(a), the levels of spontaneous apoptosis measured with TUNEL were higher in AT than in normal cells. Higher rates of spontaneous apoptosis in AT lymphoblasts have been described before [33] and are confirmed by the results obtained in the present study with both apoptotic cell detection assays (total Annexin-V-positive cells before irradiation: 5.2% in normal cells versus 10.9% in AT cells; test, ; TUNEL: 3.7% in AT cells versus 1.7% in normal cells; test, ). At early postirradiation times, the fraction of TUNEL-positive cells remains low in both cell lines, but they increase at 48 hours pIR and reach maximum levels at 72 hours pIR, being of 17.2% in normal and 32.4% in AT cells ( test, ). Although both Annexin-V/PI and TUNEL methodologies measure apoptosis, they seem to detect correlative stages of this process. At twenty-four hours after irradiation, there has been an increase of cells undergoing EA and evolving to a LA stage compared to unirradiated cells, while yet very few cells are positive for TUNEL staining. EA and LA fractions reach a plateau level at 48 hours pIR, while at this time there is an increasing frequency of TUNEL-positive events. Because TUNEL methodology detects extensive DNA fragmentation, TUNEL-positive cells might undergo a later apoptotic stage than those signaled with Annexin. In this way, the combination of the results obtained with the Annexin-V/PI and the TUNEL procedures renders a dynamic picture of the apoptotic process in the lymphoblast cells analyzed.

Lymphocytes are removed, both physiologically and after irradiation, by a p53- and caspase-dependent apoptotic pathway that leads to DNA cleavage [19, 34, 35]. The role of the ATM protein in triggering this IR-induced apoptotic response has been examined using different experimental systems in AT lymphoblasts, AT lymphoblastoid cell lines (LCLs), and Atm−/− mouse thymocytes with conflicting results. Lymphocytes from AT patients were found to have an increased spontaneous apoptotic level [33]. Also, a normal apoptotic response after IR was demonstrated in Atm−/− mouse cells [26] and in lymphocytes from AT patients [27]. Variable results have been described in AT LCLs, although most of them displayed a normal apoptotic response to IR [28, 36]. To ultimately determine p53 status, we analyzed p53 presence and its activation after IR. Levels of p21, a p53 effector involved in cell cycle arrest at G1 and S phases after DNA damage induction [37], have also been analyzed. As shown in Figure 1(c), despite ATM absence, p53 was effectively induced in normal and AT cells at 24 hours pIR, when the fraction of apoptotic cells starts to increase. Consistent with greater apoptotic induction, levels of activated p53 are still high in AT cells at 48 hours pIR. Induction of p21 is observed in both cell lines although higher expression is observed in normal than in AT cells. In this regard, it has been suggested that ATM regulates distinct p53-dependent pathways that selectively trigger checkpoint arrest or apoptosis. For example, effective p53 induction coupled with checkpoint failure and a normal apoptotic response after IR has been described in ATM deficient cells [26, 28, 38, 39]. In agreement with these works, normal cells efficiently arrest at G1 after irradiation while the AT lymphoblastoid cell line tested in this study undergoes high apoptosis rates along with G1 checkpoint failure (see Section 2). Bax, another p53 target involved in activation of caspases, shows a similar expression in both LCLs. The cleaved fragment of caspase 3 is detected only after irradiation in both cell lines but in AT cells its expression is still visible at 72 hours, consistent with higher frequency of apoptotic AT cells at this time point. Altogether, our results are in agreement with a role for ATM selectively activating p53 to regulate cell-cycle checkpoint but not apoptosis. In this regard, ATM- and Rad3-related (ATR), Chk2 and DNA-PKcs have been proposed as candidates to regulate IR-induced apoptosis in AT cells [3840].

2.2. Radiation-Induced Mitotic Catastrophe Is a More Relevant Cell Death Process in AT Lymphoblasts Than in Its Normal Counterparts

We proceeded by analyzing cell cycle progression after irradiation. As shown in Figure 2(a), normal lymphoblasts are efficiently arrested at G1, as demonstrated by a diminution of the S fraction at 24 h pIR that prevails up to 72 h. As expected, impairment of proper G1 arrest in the AT LCL was demonstrated by no noticeable decrease in the S fraction at 24 hours pIR, and later decreases were low when compared to normal cells. These results are consistent with the Western blot results showing a weak induction of p21 in AT cells after irradiation (Figure 1(c)) and are in agreement with the ATM deficiency cell phenotype, which is characterized by impairment of G1 and intra-S checkpoint activation upon DNA damage infliction. This leads to cell cycle progression of cells bearing unresolved DNA damage [3, 41]. These cells are efficiently arrested in G2 [42] unless the DNA damage has been inflicted during G2 phase, in which case ATM deficient cells proceed into mitosis [43]. In any case, damaged cells that surpass G1 and/or G2 checkpoints become later arrested in mitosis (M) because of spindle anaphase checkpoint (SAC). In this work, cells were irradiated during their exponential growth, implying that many AT cells will surpass G1 and intra-S checkpoints and will be arrested at G2, while those AT cells irradiated during G2 phase will surpass the G2 checkpoint and arrest in M by SAC. Remarkably, our results show that AT lymphoblasts significantly accumulate at G2/M after irradiation at all times analyzed (Figure 2(a)), suggesting that, besides cells arrested at G2 checkpoint, some of them might remain in M phase.

Persistent arrest at G2/M boundaries after DNA damage infliction is a first indicator of mitotic catastrophe (MC), so we aimed to analyze the possibility that MC contributes to cell death in AT cells. MC has been described as an oncosuppressive mechanism that, in order to avoid accumulation of genomic instability, senses this mitotic failure and responds to it by driving the cell to death during mitosis [20]. Sometimes, some of these cells do not die during mitosis and eventually overcome SAC signaling and “slip” into the next interphase without dividing. These cells may reenter the cell cycle and reduplicate its DNA content, turning into the accumulation of tetraploid cells within the population. Indeed, AT lymphoblasts showed an increasing frequency of cells with a 4N DNA content that reached 5.6% at 72 hours after irradiation (Figures 2(a) and 2(b)). Although small, this fraction was higher than in normal lymphoblasts, whose tetraploid population was lower than 0.7% at all times analyzed. To further confirm these results, we quantified the centrosome number, as cells that skip mitosis and reenter the cell cycle will reduplicate their centrosomes along with DNA. Centrosomes were scored by means of immunofluorescent pericentrin detection and cells were classified into those having a normal number of centrosomes (1 centrosome in interphase and 2 centrosomes in S, G2, and M phases) or an aberrant number of centrosomes (more than 2). As shown in Figure 2(b), the basal frequency of AT cells with >2 centrosomes was very low, but it strikingly increased at 48 hours after irradiation, when it reached almost 3% of the cell population and correlated with the appearance of a 4N cell population (Figure 2(b)). In contrast, the fraction of normal lymphoblasts with an abnormal number of centrosomes did not reach 1% of the population during the 48 h analyzed ( test, ). Thus, some AT cells are able to reach mitosis despite defective repair. Eventually, some of them skip M phase, giving raise to the appearance of a tetraploid population together with an increasing population of cells with an abnormal centrosome number. Polyploid cells with extra centrosomes are prone to form transient multipolar mitotic spindles, which can either directly trigger mitotic death or result in the generation of aneuploid daughter cells. A small fraction of these cells might survive and enter a mitotic round that is also likely to be catastrophic [20]. Because the MC mechanism can ultimately culminate in apoptotic cell death [20], we propose that this mechanism contributes to the radiation-induced apoptotic levels detected in AT lymphoblasts.

2.3. Viable AT Lymphoblasts Display Higher Levels of Radiation-Induced DNA Damage and Delayed DSB Repair at Long Times after Irradiation

We next aimed to examine the levels of radiation-induced DNA damage in both lymphoblast cell lines. To this end, we analyzed γH2AX foci corresponding to radiation-induced DSBs in viable cells—those negative for TUNEL (Figure 3(a)). Figure 3(b) shows that, 24 h after irradiation, 64.1% of the normal lymphoblasts have γH2AX foci, a 3.2-fold increase compared to unirradiated cells. Within the same time interval, viable AT lymphoblasts displayed a 7-fold increase, as 87% of them showed γH2AX foci ( test, ). At 72 h pIR normal cells have repaired most of their DSBs and only 22.2% of them have γH2AX foci, while this fraction is still around 50% in AT lymphoblasts ( test, ). All together, these results reflect the DNA repair impairment of AT cells, which repair most of the DSBs in a fast and efficient way, while a subset of breaks remains unrepaired for long times, even days, after DNA damage infliction [3, 1012, 44]. In agreement with that, our results show that AT cells, despite showing an initial decline in the fraction of cells displaying γH2AX foci, are unable to efficiently proceed to further diminish this population and accumulate high numbers of residual DSBs, even at very long times after DNA damage has been induced.

After that, we scored the number of γH2AX foci in the TUNEL-negative cells and classify them into two groups: cells with less than 10 γH2AX foci and cells with 10 or more γH2AX foci (Figure 3(b)). Only a small fraction of the normal cells accumulated 10 or more γH2AX foci, reaching a peak of ~18% at 24 hours pIR and declining thereafter. On the contrary, most of the irradiated AT cells accumulated 10 or more γH2AX foci, reaching a maximum of around 75% at 24 hours pIR ( test, ). From 24 to 72 hours after irradiation, 85 to 70% of the γH2AX-positive AT cells carry 10 or more DSBs while this frequency is much lower in normal cells (27 to 12%). Thus, after irradiation, AT cells accumulate more cells with DSBs and more DSBs/cell than their normal counterparts.

The results presented here suggest that DSB repair might be inversely correlated with apoptosis induction. Indeed, at 48 hours pIR, the percentage of normal cells with ≥10 γH2AX foci is low (6.3%) and it coincides with the stabilization of the TUNEL-positive rate (around 17%). On the other hand, at 48 hours pIR, still most of AT cells have ≥10 γH2AX foci (43.3%) and TUNEL rates continue to increase at 72 hours pIR (from 26 to 32%; Figure 3(b)). In agreement with that, recent studies have revealed that some residual 53BP1, Rad51, and γH2AX foci remain in cells for a relatively long time after irradiation and have indicated an inverse correlation between the number of residual foci and the surviving fraction of cells [4549]. Similarly, a correlation between a higher rate of foci loss and a higher clonogenic surviving fraction in ten different cancer cell lines has been described [50]. Finally, it is worth noting that the fraction of AT cells with less than 10 γH2AX foci remains stable before and after irradiation and is hardly changed along with the apoptotic rate (Figure 3(b)), thus discarding this subpopulation of cells as that with more probabilities of undergoing IR-induced apoptosis. This result is in agreement with other studies describing that low background levels of foci (<3 foci per cell) scored at 24 hours after irradiation were correlated with cell survival [14, 51].

2.4. Apoptotic AT Cells Accumulate More Residual DSBs Than Normal Lymphoblasts

To further analyze this possibility, we proceeded to analyze radiation-induced DSBs in normal and AT lymphoblasts undergoing apoptosis. The characteristic DSB-signaling processes of the DDR, such as phosphorylation of histone H2AX forming visible foci, are eventually abolished in cells undergoing last stages of apoptosis, probably due to DNA condensation [52]. Consequently, no γH2AX foci were scored in TUNEL-positive cells (Figure 3(a)). We reasoned that earlier apoptotic stages, such as those detected with Annexin-V/PI methodology, would better allow the detection of radiation-induced DSBs. To this end, AT and normal lymphoblasts were irradiated and enriched populations of early apoptotic (An+/PI−) and late apoptotic/necrotic (An+/PI+) cells were obtained by flow sorting at 48 hours after irradiation. Immediately after sorting, cells were fixed on slides and γH2AX immunofluorescence was performed. This procedure resulted in the loss of Annexin-V and PI staining, allowing for reliable identification of γH2AX signaling. In all the populations analyzed we found a fraction of cells displaying a pan-nuclear γH2AX staining (Figure 3(a)). This kind of staining has been related to apoptosis induced by several DNA damaging agents and is concurrent with the initiation of DNA fragmentation resulting from the apoptotic process [53, 54]. This fraction of cells was taken into account when calculating the percentages shown in the figures. At the time point selected after irradiation (48 hours), the fraction of cells undergoing early and late apoptosis was at its maximum in both cell lines. Cells undergoing early apoptosis (An+/PI−) were 4.8% in normal and 12.5% in AT cells, while those undergoing late apoptosis (An+/PI+) were 7.5% and 19.3% in normal and AT LCL, respectively (Figure 1(a)).

Within the above mentioned fraction of cells undergoing early apoptosis (An+/PI−), most of them had γH2AX foci—64.8% of the normal lymphoblasts and 51.2% of the AT cells (Figure 3(c)). Nonetheless, most of the cells undergoing early apoptosis had less than 10 γH2AX foci/cell in normal cells (47.6%) but ≥10 γH2AX foci/cell in AT cells (28.4%), demonstrating that also the AT cells that initiate apoptosis (An+/PI−) accumulate a significantly higher number of DSBs than normal cells ( test; ). As normal lymphoblasts enter in later apoptotic/necrotic stages (An+/PI+), the frequency of cells with less than 10 γH2AX foci is sharply reduced (from 47.6% to 19.9%; 2.4-fold reduction), while the fraction of cells with ≥10 γH2AX foci is more or less maintained (14%). Similarly, the frequency of AT lymphoblasts undergoing later apoptotic stages (An+/PI+) that present less than 10 γH2AX foci is reduced, while the population of cells with ≥10 γH2AX foci is increased with respect to early apoptosis and to normal cells (75% of the γH2AX-positive AT lymphoblasts). Thus, AT lymphoblasts accumulate more DSBs/cell than their normal counterparts, also while undergoing apoptosis ( test; ).

It is important to note that An+/PI− cells might be considered viable, as early apoptosis is believed to be reversible if the conditions inducing apoptosis are removed [5557]. Moreover, it has been suggested that DNA repair is involved in this reversibility [58]. Thus, while undergoing early apoptosis, cells might be able to perform some degree of DSB repair that leads to reduction of γH2AX foci-positive cells in later apoptotic stages. Most probably, cells that carry a larger amount of DSBs have a lower probability of eventually performing successful repair; thus cells with ≥10 γH2AX foci accumulate at later stages of apoptosis. In this work, cells undergoing late apoptosis are those accumulating more DSBs, and the cell line with impaired repair activity is the one carrying more residual DSBs and displaying higher rates of cell death. Similar results have been very recently described in which cells carrying Rad51 foci at 24 hours pIR are the ones more likely to die [44]. It cannot be concluded that accumulation of ≥10 γH2AX foci signals cells to undergo apoptosis, as γH2AX foci dose-response may depend on cell type, time allowed after irradiation, and the cell cycle phase in the moment of irradiation among other factors. Nonetheless, these results support the notion that persistence of residual DSBs signals those cells that are more likely to undergo cell death.

3. Conclusions

Annexin-V/PI and TUNEL methodologies have been used to analyze IR-induced apoptosis. These methodologies seem to detect subtle differences in apoptotic frequencies that might correspond to progressive apoptotic stages, as maximum levels of Annexin-V-positive cells are reached earlier than maximum levels of TUNEL-positive cells. Annexin-V/PI allows discrimination between cells undergoing early and late apoptosis as well as fast scoring of more cells. TUNEL detection on slides and subsequent microscope analysis allows the combination of TUNEL and protein immunodetection—like γH2AX—and the analysis of these events in the apoptotic and the healthy fraction at the same time.

The results in this work show that AT LCL efficiently undergoes IR-induced apoptosis to a higher level than its normal counterpart at all times analyzed. Along with accumulation of residual DSBs, indicators of mitotic catastrophe such as prolonged G2/M arrest and DNA and centrosomes reduplication are found in irradiated AT cells, which also contribute to the apoptotic levels scored. In these cells, apoptosis is accompanied with p53 induction and cleavage of caspase 3, while they show low levels of p21 induction that correlate with impairment of G1 and intra-S checkpoint activation after irradiation. These results agree with a role for ATM selectively activating p53 to regulate apoptosis and not cell cycle checkpoint. Accumulation of radiation-induced unrepaired DSBs contributes to cell death. For this reason, viable cells that are undergoing apoptosis (Annexin-positive) have been isolated in both cell lines and γH2AX foci have been scored. The results show that these are the cells accumulating more DSBs per cell. As cells progress from EA to LA, the fraction of cells with fewer γH2AX foci decreases in both AT and normal cells, while cells with more than 10 γH2AX foci accumulate in LA, especially in AT cells—consistent with their DNA repair defect. These results support the notion that persistence of residual DSBs signals those cells that are more likely to undergo cell death and that scoring of γH2AX foci might function as a predictive tool to assess radiation-induced apoptosis.

4. Material and Methods

4.1. Cell Culture and γ-Irradiation

EBV-transformed human lymphoblastoid cell lines (LCLs) GM08436A (derived from a child suffering from Ataxia-Telangiectasia) and GM09622 (derived from a sex and age matched control) were obtained from the Coriell Cell Culture Repositories. Cells were grown in suspension in RPMI 1640 medium with GlutaMAX-I (Life Technologies, CA, USA) supplemented with 15% fetal bovine serum and kept in the incubator at 37°C and 5% CO2 atmosphere. When indicated, cells were irradiated with 5 Gy γ-rays using an IBL-437C R-137 Cs irradiator, with a dose rate of 5.10 Gy/min.

4.2. Apoptosis Detection
4.2.1. Annexin-V-Fluorescein Assay

The Annexin-V/propidium iodide (PI) assay was performed following the manufacturer’s instructions (Annexin-V-FLUOS Staining Kit, Roche, Switzerland). Briefly, lymphoblast cells were collected, centrifuged, and washed in 1xPBS. The cell pellet was resuspended in freshly prepared Annexin-V-FLUOS labeling solution with PI and incubated for 15 minutes (min) at room temperature, in the dark. Cells were analyzed on a FACSCalibur flow cytometer (Becton-Dickinson, CA, USA) using 488 nm excitation and 530/30 nm band pass filter for fluorescein detection and a FL2 photomultiplier and band pass filter 585/42 nm for PI detection after electronic compensation. Flow cytometry analysis was done with the CellQuest software (Becton-Dickinson, CA, USA). Cells were classified into the following fractions: (a) viable cells (An−/PI−) were impermeable for PI and also did not bind Annexin-V (An); (b) early apoptotic cells (An+/PI−) bound An and were PI impermeable; (c) late apoptotic or, also called, secondary necrotic cells (An+/PI+) bound An and were PI permeable; (d) primary necrotic cells (An−/PI+) only displayed PI staining. When indicated, cell sorting of enriched populations of An+/PI− and An+/PI+ cells was performed with a FACS Aria SORP sorting cytometer (Becton-Dickinson Biosciences, CA, USA) using a 488 nm excitation laser and 525 nm band pass filter for fluorescein detection and a 350 nm excitation UV laser and 660/400 nm band pass filter for PI detection. Cells obtained after sorting were dropped on poly-L-lysine coated slides and allowed to attach for 3 min before proceeding with immunofluorescence.

4.2.2. TUNEL Assay

The TUNEL assay was performed following the manufacturer’s instructions (In Situ Cell Death Detection Kit, Fluorescein, Roche, Switzerland). Briefly, lymphoblasts were centrifuged, washed with 1xPBS, and dropped on poly-L-lysine coated slides. Cells were then fixed with 2% paraformaldehyde for 20 min at room temperature and permeabilized with 0.1% Triton-X100 and 0.1% sodium citrate in 1xPBS for 5 min in ice. The TUNEL mix was applied to the cells following the manufacturer’s instructions and allowed to be incubated at 37°C for 40 minutes. Before analysis, Vectashield Mounting Medium for fluorescence (Vector Laboratories Inc., CA, USA) supplemented with 4′,6-diamino-2-phenylindole (DAPI) was applied. TUNEL analysis was performed with an Olympus BX41TF epifluorescence microscope equipped with an Olympus U-TVIX digital camera using the Isis v5.4.9 software (MetaSystems, Germany).

4.3. Cell Cycle Analysis

Lymphoblasts were washed in 1xPBS, centrifuged, and kept in 70% ethanol at −20°C until analysis. Cells were then centrifuged, washed with 1xPBS, and resuspended in 1 mL of freshly prepared PI/Triton/RNAsa solution: 0.1%Triton-X100, 2 mg RNAsa A (DNAsa free), and 200 μL of 1 mg/mL PI. After 15 min incubation at 37°C, DNA content was measured on a FACSCalibur flow cytometer (Becton-Dickinson, CA, USA). Red fluorescence of PI-stained nuclei was excited at 488 nm with an argon laser and was collected through a 670 nm long pass filter detection into the FL3 photomultiplier tube on a linear scale, at a flow rate of 12 mL/min (low). Cell cycle analysis of the DNA histograms of integrated red fluorescence was performed with CellQuest software (Becton-Dickinson, CA, USA).

4.4. Immunofluorescence

Immunodetection of γH2AX was performed on the same samples previously analyzed for TUNEL or sorted after Annexin-V/PI staining. Pericentrin detection was performed on newly obtained samples of irradiated lymphoblasts allowed to attach onto poly-L-lysine slides. Cells were fixed for 15 min in 4% paraformaldehyde and permeabilized in 1xPBS-0.5% Triton-X100 solution for 15 min. After 30 minutes of blocking with 0.1% Tween20 and 5% FBS, mouse anti-γH2AX (Ser139) (Upstate/Millipore, MA, USA) or rabbit anti-pericentrin (Abcam, UK) was applied at a 1 : 1000 concentration and allowed to incubate for 1 hour at room temperature. Anti-mouse Cy3 (Amersham Biosciences/GE Healthcare, NJ, USA) and anti-rabbit A488 (Invitrogen/Molecular Probes, OR, USA) secondary antibodies were applied at 1 : 1000 final concentration for 45 minutes at room temperature, followed by extensive washing. Before analysis, Vectashield Mounting Medium for fluorescence (Vector Laboratories Inc., CA, USA) supplemented with DAPI was applied. Slides were analyzed using an Olympus BX41TF epifluorescence microscope equipped with an Olympus U-TVIX digital camera using the Isis v5.4.9 software (MetaSystems, Germany).

4.5. Western Blotting

Cells were collected by centrifugation, washed with PBS, treated with RIPA lysis buffer, and sonicated. Whole-cell extracts were loaded onto a 10% SDS-polyacrylamide gel that was run at 150 V for 50 minutes in a Bio-Rad mini-gel system. Proteins were transferred to a nitrocellulose membrane (30 V, 90 minutes) and blocked for 1 h at room temperature in 5% BSA brought to 37°C or with nonfat milk at 4°C. Primary antibodies used were mouse monoclonal anti-p53 (Santa Cruz Biotechnology, Inc., TX, USA), rabbit monoclonal anti-phospho-p53 (Ser15) (Thermo Fisher Scientific, MA, USA), rabbit monoclonal anti-p21 (Abcam, UK), rabbit monoclonal anti-Bax (Abcam, UK), rabbit polyclonal anti-active caspase 3 (Abcam, UK), and mouse anti-GAPDH (Abcam, UK). Membranes were washed with TTBS (Tris 10 mM, NaCl 150 mM, and 0.005% Tween20) and incubated for 1 hour at room temperature with secondary antibody, goat anti-rabbit or goat anti-mouse, conjugated to horseradish peroxidase (Upstate/Millipore, MA, USA). Proteins were visualized using Immobilon Western kit (Upstate/Millipore, MA, USA) and the signal was captured with ChemiDoc XRS (Bio-Rad, CA, USA).

4.6. Statistical Analysis

The statistical analysis was performed using GraphPad InStat version 3.05 (GraphPad Software Inc., CA, USA).

Disclosure

The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the paper.

Conflict of Interests

The authors declare that they have no competing financial interests.

Authors’ Contribution

Marta Martín and Anna Genescà developed the study concept and design. Testing and data collection and analysis were performed by Teresa Anglada, Marta Martín, Mariona Terradas, and Laia Hernández. Marta Martín and Anna Genescà wrote the paper and approved its final version for submission.

Acknowledgments

This work was funded by grants from Consejo de Seguridad Nuclear (CSN 2012-0001) and EURATOM (Dark.Risk GA 323216). Anna Genescà Laboratory is supported by Generalitat de Catalunya (2009SGR-282). Laia Hernández is supported by the Universitat Autònoma de Barcelona Ph.D. programme fellowship. The authors would like to thank Dr. Dik van Gent and Dr. Humberto Sánchez for their valuable comments. They also thank the Radiological Protection Unit at Universitat Autònoma de Barcelona for sample irradiation and the Cytometry Service from the Centres Científics i Teconològics (CCiT), Universitat de Barcelona (UB), for cell sorting.

References

  1. C. J. Bakkenist and M. B. Kastan, “Initiating cellular stress responses,” Cell, vol. 118, no. 1, pp. 9–17, 2004. View at: Publisher Site | Google Scholar
  2. E. U. Kurz and S. P. Lees-Miller, “DNA damage-induced activation of ATM and ATM-dependent signaling pathways,” DNA Repair, vol. 3, no. 8-9, pp. 889–900, 2004. View at: Publisher Site | Google Scholar
  3. Y. Shiloh, “ATM and related protein kinases: safeguarding genome integrity,” Nature Reviews Cancer, vol. 3, no. 3, pp. 155–168, 2003. View at: Publisher Site | Google Scholar
  4. A. Di Leonardo, S. P. Linke, K. Clarkin, and G. M. Wahl, “DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts,” Genes & Development, vol. 8, no. 21, pp. 2540–2551, 1994. View at: Publisher Site | Google Scholar
  5. M. B. Kastan, O. Onyekwere, D. Sidransky, B. Vogelstein, and R. W. Craig, “Participation of p53 protein in the cellular response to DNA damage,” Cancer Research, vol. 51, no. 23, pp. 6304–6311, 1991. View at: Google Scholar
  6. E. P. Rogakou, D. R. Pilch, A. H. Orr, V. S. Ivanova, and W. M. Bonner, “DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139,” The Journal of Biological Chemistry, vol. 273, no. 10, pp. 5858–5868, 1998. View at: Publisher Site | Google Scholar
  7. E. P. Rogakou, C. Boon, C. Redon, and W. M. Bonner, “Megabase chromatin domains involved in DNA double-strand breaks in vivo,” The Journal of Cell Biology, vol. 146, no. 5, pp. 905–916, 1999. View at: Publisher Site | Google Scholar
  8. M. Löbrich, A. Shibata, A. Beucher et al., “γH2AX foci analysis for monitoring DNA double-strand break repair: strengths, limitations and optimization,” Cell Cycle, vol. 9, no. 4, pp. 662–669, 2010. View at: Publisher Site | Google Scholar
  9. O. A. Sedelnikova, E. P. Rogakou, I. G. Panyutin, and W. M. Bonner, “Quantitative detection of 125IdU-induced DNA double-strand breaks with gamma-H2AX antibody,” Radiation Research, vol. 158, no. 4, pp. 486–492, 2002. View at: Google Scholar
  10. M. Kühne, E. Riballo, N. Rief, K. Rothkamm, P. A. Jeggo, and M. Löbrich, “A double-strand break repair defect in ATM-deficient cells contributes to radiosensitivity,” Cancer Research, vol. 64, no. 2, pp. 500–508, 2004. View at: Publisher Site | Google Scholar
  11. M. Martín, M. Terradas, G. Iliakis, L. Tusell, and A. Genescà, “Breaks invisible to the DNA damage response machinery accumulate in ATM-deficient cells,” Genes Chromosomes and Cancer, vol. 48, no. 9, pp. 745–759, 2009. View at: Publisher Site | Google Scholar
  12. E. Riballo, M. Kühne, N. Rief et al., “A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to γ-H2AX foci,” Molecular Cell, vol. 16, no. 5, pp. 715–724, 2004. View at: Publisher Site | Google Scholar
  13. J. P. Banáth, S. H. MacPhail, and P. L. Olive, “Radiation sensitivity, H2AX phosphorylation, and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines,” Cancer Research, vol. 64, no. 19, pp. 7144–7149, 2004. View at: Publisher Site | Google Scholar
  14. D. Klokov, S. M. MacPhail, J. P. Banáth, J. P. Byrne, and P. L. Olive, “Phosphorylated histone H2AX in relation to cell survival in tumor cells and xenografts exposed to single and fractionated doses of X-rays,” Radiotherapy and Oncology, vol. 80, no. 2, pp. 223–229, 2006. View at: Publisher Site | Google Scholar
  15. H. Mahrhofer, S. Bürger, U. Oppitz, M. Flentje, and C. S. Djuzenova, “Radiation induced DNA damage and damage repair in human tumor and fibroblast cell lines assessed by histone H2AX phosphorylation,” International Journal of Radiation Oncology, Biology, Physics, vol. 64, no. 2, pp. 573–580, 2006. View at: Publisher Site | Google Scholar
  16. T. Yoshikawa, G. Kashino, K. Ono, and M. Watanabe, “Phosphorylated H2AX foci in tumor cells have no correlation with their radiation sensitivities,” Journal of Radiation Research, vol. 50, no. 2, pp. 151–160, 2009. View at: Publisher Site | Google Scholar
  17. M. Castedo, J.-L. Perfettini, T. Roumier, K. Andreau, R. Medema, and G. Kroemer, “Cell death by mitotic catastrophe: a molecular definition,” Oncogene, vol. 23, no. 16, pp. 2825–2837, 2004. View at: Publisher Site | Google Scholar
  18. H. Vakifahmetoglu, M. Olsson, and B. Zhivotovsky, “Death through a tragedy: mitotic catastrophe,” Cell Death and Differentiation, vol. 15, no. 7, pp. 1153–1162, 2008. View at: Publisher Site | Google Scholar
  19. L. Galluzzi, I. Vitale, J. M. Abrams et al., “Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012,” Cell Death and Differentiation, vol. 19, no. 1, pp. 107–120, 2012. View at: Publisher Site | Google Scholar
  20. I. Vitale, L. Galluzzi, M. Castedo, and G. Kroemer, “Mitotic catastrophe: a mechanism for avoiding genomic instability,” Nature Reviews. Molecular cell biology, vol. 12, no. 6, pp. 385–392, 2011. View at: Publisher Site | Google Scholar
  21. R. W. Bailey, T. Nguyen, L. Robertson et al., “Sequence of physical changes to the cell membrane during glucocorticoid-induced apoptosis in S49 lymphoma cells,” Biophysical Journal, vol. 96, no. 7, pp. 2709–2718, 2009. View at: Publisher Site | Google Scholar
  22. A. Hochreiter-Hufford and K. S. Ravichandran, “Clearing the dead: apoptotic cell sensing, recognition, engulfment, and digestion,” Cold Spring Harbor Perspectives in Biology, vol. 5, no. 1, Article ID a008748, 2013. View at: Publisher Site | Google Scholar
  23. I. Vermes, C. Haanen, H. Steffens-Nakken, and C. Reutellingsperger, “A novel assay for apoptosis Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V,” Journal of Immunological Methods, vol. 184, no. 1, pp. 39–51, 1995. View at: Publisher Site | Google Scholar
  24. Z. Bacso and J. F. Eliason, “Measurement of DNA damage associated with apoptosis by laser scanning cytometry,” Cytometry, vol. 45, no. 3, pp. 180–186, 2001. View at: Publisher Site | Google Scholar
  25. J. B. P. Barber, C. M. L. West, A. E. Kiltie, S. A. Roberts, and D. Scott, “Detection of individual differences in radiation-induced apoptosis of peripheral blood lymphocytes in normal individuals, ataxia telangiectasia homozygotes and heterozygotes, and breast cancer patients after radiotherapy,” Radiation Research, vol. 153, no. 5, pp. 570–578, 2000. View at: Publisher Site | Google Scholar
  26. C. Barlow, K. D. Brown, C.-X. Deng, D. A. Tagle, and A. Wynshaw-Boris, “Atm selectively regulates distinct p53-dependent cell-cycle checkpoint and apoptotic pathways,” Nature Genetics, vol. 17, no. 4, pp. 453–456, 1997. View at: Publisher Site | Google Scholar
  27. D. G. Bebb, P. J. Warrington, G. De Jong et al., “Radiation induced apoptosis in ataxia telangiectasia homozygote, heterozygote and normal cells,” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 476, no. 1-2, pp. 13–20, 2001. View at: Publisher Site | Google Scholar
  28. M. Fernet, S. Angele, T. Dörk, and J. Hall, “Variation in radiation-induced apoptosis in ataxia telangiectasia lymphoblastoid cell lines,” International Journal of Radiation Biology, vol. 79, no. 3, pp. 193–202, 2003. View at: Publisher Site | Google Scholar
  29. B. Humar, H. Müller, and R. J. Scott, “Elevated frequency of p53-independent apoptosis after irradiation increases levels of DNA breaks in ataxia telangiectasia lymphoblasts,” International Journal of Radiation Biology, vol. 72, no. 3, pp. 257–269, 1997. View at: Publisher Site | Google Scholar
  30. A. E. Meijer, B. Zhivotovsky, and R. Lewensohn, “Epstein-Barr virus-transformed lymphoblastoid cell lines of ataxia telangiectasia patients are defective in X-ray-induced apoptosis,” International Journal of Radiation Biology, vol. 75, no. 6, pp. 709–716, 1999. View at: Publisher Site | Google Scholar
  31. Y.-Q. Shi, L. Li, O. Sanal et al., “High levels of delayed radiation-induced apoptosis observed in lymphoblastoid cell lines from ataxia-telangiectasia patients,” International Journal of Radiation Oncology Biology Physics, vol. 49, no. 2, pp. 555–559, 2001. View at: Publisher Site | Google Scholar
  32. G. R. Bicknell, R. T. Snowden, and G. M. Cohen, “Formation of high molecular mass DNA fragments is a marker of apoptosis in the human leukaemic cell line, U937,” Journal of Cell Science, vol. 107, no. 9, pp. 2483–2489, 1994. View at: Google Scholar
  33. E. Duchaud, A. Ridet, D. Stoppa-Lyonnet, N. Janin, E. Moustacchi, and F. Rosselli, “Deregulated apoptosis in ataxia telangiectasia: association with clinical stigmata and radiosensitivity,” Cancer Research, vol. 56, no. 6, pp. 1400–1404, 1996. View at: Google Scholar
  34. C. G. Proud, “Regulation of mammalian translation factors by nutrients,” European Journal of Biochemistry, vol. 269, no. 22, pp. 5338–5349, 2002. View at: Publisher Site | Google Scholar
  35. A. Strasser, “Life and death during lymphocyte development and function: evidence for two distinct killing mechanisms,” Current Opinion in Immunology, vol. 7, no. 2, pp. 228–234, 1995. View at: Publisher Site | Google Scholar
  36. A. E. Meijer, J. Ekedahl, B. Joseph et al., “High-LET radiation induces apoptosis in lymphoblastoid cell lines derived from ataxia-telangiectasia patients,” International Journal of Radiation Biology, vol. 77, no. 3, pp. 309–317, 2001. View at: Publisher Site | Google Scholar
  37. A. L. Gartel and S. K. Radhakrishnan, “Lost in transcription: p21 repression, mechanisms, and consequences,” Cancer Research, vol. 65, no. 10, pp. 3980–3985, 2005. View at: Publisher Site | Google Scholar
  38. A. Hirao, A. Cheung, G. Duncan et al., “Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner,” Molecular and Cellular Biology, vol. 22, no. 18, pp. 6521–6532, 2002. View at: Publisher Site | Google Scholar
  39. S. Wang, M. Guo, H. Ouyang et al., “The catalytic subunit of DNA-dependent protein kinase selectively regulates p53-dependent apoptosis but not cell-cycle arrest,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 4, pp. 1584–1588, 2000. View at: Publisher Site | Google Scholar
  40. B. Vogelstein and K. W. Kinzler, “Cancer genes and the pathways they control,” Nature Medicine, vol. 10, no. 8, pp. 789–799, 2004. View at: Publisher Site | Google Scholar
  41. K. K. Khanna, M. F. Lavin, S. P. Jackson, and T. D. Mulhern, “ATM, a central controller of cellular responses to DNA damage,” Cell Death and Differentiation, vol. 8, no. 11, pp. 1052–1065, 2001. View at: Publisher Site | Google Scholar
  42. D. Scott, A. R. Spreadborough, and S. A. Roberts, “Radiation-induced G2 delay and spontaneous chromosome aberrations in ataxia-telangiectasia homozygotes and heterozygotes,” International Journal of Radiation Biology, vol. 66, no. 6, pp. S157–S163, 1994. View at: Publisher Site | Google Scholar
  43. H. Beamish and M. F. Lavin, “Radiosensitivity in ataxia-telangiectasia: anomalies in radiation-induced cell cycle delay,” International Journal of Radiation Biology, vol. 65, no. 2, pp. 175–184, 1994. View at: Publisher Site | Google Scholar
  44. M. Gatei, B.-B. Zhou, K. Hobson, S. Scott, D. Young, and K. K. Khanna, “Ataxia telangiectasia mutated (ATM) kinase and ATM and Rad3 related kinase mediate phosphorylation of Brca1 at distinct and overlapping sites. In vivo assessment using phospho-specific antibodies,” Journal of Biological Chemistry, vol. 276, no. 20, pp. 17276–17280, 2001. View at: Publisher Site | Google Scholar
  45. J. P. Banáth, D. Klokov, S. H. MacPhail, C. A. Banuelos, and P. L. Olive, “Residual γH2AX foci as an indication of lethal DNA lesions,” BMC Cancer, vol. 10, article 4, 2010. View at: Publisher Site | Google Scholar
  46. E. Dikomey, I. Brammer, J. Johansen, S. M. Bentzen, and J. Overgaard, “Relationship between DNA double-strand breaks, cell killing, and fibrosis studied in confluent skin fibroblasts derived from breast cancer patients,” International Journal of Radiation Oncology Biology Physics, vol. 46, no. 2, pp. 481–490, 2000. View at: Publisher Site | Google Scholar
  47. H. D. Halicka, X. Huang, F. Traganos, M. A. King, W. Dai, and Z. Darzynkiewicz, “Histone H2AX phosphorylation after cell irradiation with UV-B: relationship to cell cycle phase and induction of apoptosis,” Cell Cycle, vol. 4, no. 2, pp. 339–345, 2005. View at: Google Scholar
  48. H. Kunogi, T. Sakanishi, N. Sueyoshi, and K. Sasai, “Prediction of radiosensitivity using phosphorylation of histone H2AX and apoptosis in human tumor cell lines,” International Journal of Radiation Biology, vol. 90, no. 7, pp. 587–593, 2014. View at: Publisher Site | Google Scholar
  49. A. Menegakis, A. Yaromina, W. Eicheler et al., “Prediction of clonogenic cell survival curves based on the number of residual DNA double strand breaks measured by γH2AX staining,” International Journal of Radiation Biology, vol. 85, no. 11, pp. 1032–1041, 2009. View at: Publisher Site | Google Scholar
  50. S. H. Macphail, J. P. Banáth, T. Y. Yu, E. H. M. Chu, H. Lambur, and P. L. Olive, “Expression of phosphorylated histone H2AX in cultured cell lines following exposure to X-rays,” International Journal of Radiation Biology, vol. 79, no. 5, pp. 351–358, 2003. View at: Publisher Site | Google Scholar
  51. P. L. Olive and J. P. Banáth, “Kinetics of H2AX phosphorylation after exposure to cisplatin,” Cytometry Part B: Clinical Cytometry, vol. 76, no. 2, pp. 79–90, 2009. View at: Publisher Site | Google Scholar
  52. E. Marková, J. Torudd, and I. Belyaev, “Long time persistence of residual 53BP1/γ-H2AX foci in human lymphocytes in relationship to apoptosis, chromatin condensation and biological dosimetry,” International Journal of Radiation Biology, vol. 87, no. 7, pp. 736–745, 2011. View at: Publisher Site | Google Scholar
  53. E. P. Rogakou, W. Nieves-Neira, C. Boon, Y. Pommier, and W. M. Bonner, “Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139,” The Journal of Biological Chemistry, vol. 275, no. 13, pp. 9390–9395, 2000. View at: Publisher Site | Google Scholar
  54. B. Mukherjee, C. Kessinger, J. Kobayashi et al., “DNA-PK phosphorylates histone H2AX during apoptotic DNA fragmentation in mammalian cells,” DNA Repair, vol. 5, no. 5, pp. 575–590, 2006. View at: Publisher Site | Google Scholar
  55. F. J. Geske, A. C. Nelson, R. Lieberman, R. Strange, T. Sun, and L. E. Gerschenson, “DNA repair is activated in early stages of p53-induced apoptosis,” Cell Death and Differentiation, vol. 7, no. 4, pp. 393–401, 2000. View at: Publisher Site | Google Scholar
  56. A. K. Hammill, J. W. Uhr, and R. H. Scheuermann, “Annexin V staining due to loss of membrane asymmetry can be reversible and precede commitment to apoptotic death,” Experimental Cell Research, vol. 251, no. 1, pp. 16–21, 1999. View at: Publisher Site | Google Scholar
  57. H. L. Tang, K. L. Yuen, H. M. Tang, and M. C. Fung, “Reversibility of apoptosis in cancer cells,” British Journal of Cancer, vol. 100, no. 1, pp. 118–122, 2009. View at: Publisher Site | Google Scholar
  58. F. J. Geske, R. Lieberman, R. Strange, and L. E. Gerschenson, “Early stages of p53-induced apoptosis are reversible,” Cell Death and Differentiation, vol. 8, no. 2, pp. 182–191, 2001. View at: Publisher Site | Google Scholar

Copyright © 2016 Teresa Anglada et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

808 Views | 445 Downloads | 1 Citation
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.